Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ, Kollmannsberger C, Metzner B, Hartmann JT, Schleucher N, Schöffski P, Schleicher J, Rick O, Beyer J, Hossfeld D, Kanz L, Berdel WE, Andreesen R, Bokemeyer C; German Testicular Cancer Study Group. Schmoll HJ, et al. Among authors: schleucher n. J Clin Oncol. 2003 Nov 15;21(22):4083-91. doi: 10.1200/JCO.2003.09.035. Epub 2003 Oct 20. J Clin Oncol. 2003. PMID: 14568987 Clinical Trial.
First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases.
Kollmannsberger C, Nichols C, Bamberg M, Hartmann JT, Schleucher N, Beyer J, Schöfski P, Derigs G, Rüther U, Böhlke I, Schmoll HJ, Kanz L, Bokemeyer C. Kollmannsberger C, et al. Among authors: schleucher n. Ann Oncol. 2000 May;11(5):553-9. doi: 10.1023/a:1008388328809. Ann Oncol. 2000. PMID: 10907948 Free article. Clinical Trial.
Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support.
Kollmannsberger C, Schleucher N, Rick O, Metzner B, Hartmann JT, Schöffski P, Beyer J, Casper J, Sosada M, Schmoll HJ, Böhlke I, Meisner C, Kanz L, Bokemeyer C. Kollmannsberger C, et al. Among authors: schleucher n. Eur J Cancer. 2003 Apr;39(6):775-82. doi: 10.1016/s0959-8049(03)00003-0. Eur J Cancer. 2003. PMID: 12651203 Clinical Trial.
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial.
Bokemeyer C, Schleucher N, Metzner B, Thomas M, Rick O, Schmoll HJ, Kollmannsberger C, Boehlke I, Kanz L, Hartmann JT. Bokemeyer C, et al. Among authors: schleucher n. Br J Cancer. 2003 Jul 7;89(1):29-35. doi: 10.1038/sj.bjc.6600999. Br J Cancer. 2003. PMID: 12838296 Free PMC article. Clinical Trial.
Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.
Kollmannsberger C, Budach W, Stahl M, Schleucher N, Hehr T, Wilke H, Schleicher J, Vanhoefer U, Jehle EC, Oechsle K, Trarbach T, Boehlke I, Kanz L, Hartmann JT, Bokemeyer C. Kollmannsberger C, et al. Among authors: schleucher n. Ann Oncol. 2005 Aug;16(8):1326-33. doi: 10.1093/annonc/mdi252. Epub 2005 May 26. Ann Oncol. 2005. PMID: 15919686 Free article. Clinical Trial.
Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group.
Kollmannsberger C, Rick O, Derigs HG, Schleucher N, Schöffski P, Beyer J, Schoch R, Sayer HG, Gerl A, Kuczyk M, Spott C, Kanz L, Bokemeyer C. Kollmannsberger C, et al. Among authors: schleucher n. J Clin Oncol. 2002 Apr 15;20(8):2031-7. doi: 10.1200/JCO.2002.08.050. J Clin Oncol. 2002. PMID: 11956262 Clinical Trial.
23 results